Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia
暂无分享,去创建一个
P. Lavie | Abraham Weizman | T. Barnes | O. Tzischinsky | R. Epstein | O. Tzischinsky | A. Weizman | M. Poyurovsky | P. Lavie | M. Poyurovsky | R. Nave | R. Epstein | O. Tzischinsky | M. Schneidman | T.R.E. Barnes | A. Weizman | M. Schneidman | R. Nave | Peretz Lavie
[1] P. Sachdev. Akathisia and Restless Legs , 1995 .
[2] H. Lauerma,et al. Mianserin and restless legs. , 1997, International clinical psychopharmacology.
[3] Abraham Weizman,et al. Serotonergic agents in the treatment of acute neuroleptic‐induced akathisia: open‐label study of buspirone and mianserin , 1997, International clinical psychopharmacology.
[4] S. Chokroverty,et al. A clinical and polysomnographic comparison of neuroleptic-induced akathisia and the idiopathic restless legs syndrome. , 1991, Sleep.
[5] C. Fuchs,et al. Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin , 1999, British Journal of Psychiatry.
[6] P. Weiden,et al. Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study. , 1987, American Journal of Psychiatry.
[7] A. Elizur,et al. Akathisia and pseudoakathisia: clinical observations and accelerometric recordings. , 1994, The Journal of clinical psychiatry.
[8] Martin H. Teicher,et al. Quantitative assessment of psychomotor activity in patients with neuroleptic-induced akathisia , 1992, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[9] G. Simpson,et al. Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment. , 1990, Archives of general psychiatry.
[10] Zung Ww. Effect of clorazepate on depressed mood in anxious patients. , 1987 .
[11] S. Kay,et al. The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.
[12] M. Egan,et al. Diurnal variation in tardive dyskinesia , 1995, Psychiatry Research.
[13] M. Kryger,et al. Principles and Practice of Sleep Medicine , 1989 .
[14] Martin H. Teicher. Actigraphy and Motion Analysis: New Tools for Psychiatry , 1995, Harvard review of psychiatry.
[15] T. Putten. Why do schizophrenic patients refuse to take their drugs , 1974 .
[16] M. Mazurek,et al. Circadian pattern of acute, neuroleptic-induced dystonic reactions. , 1996, The American journal of psychiatry.
[17] P. Keck,et al. Polysomnographic Characteristics of Neuroleptic‐Induced Akathisia , 1991, Clinical neuropharmacology.
[18] J. Kane,et al. Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserin. , 1990, Psychopharmacology bulletin.
[19] T. Barnes. A Rating Scale for Drug-Induced Akathisia , 1989, British Journal of Psychiatry.
[20] Martin H. Teicher,et al. Circadian locomotor activity rhythms in Alzheimer's disease. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[21] P. Lavie,et al. Actigraphic measurements of sleep in rheumatoid arthritis: comparison of patients with low back pain and healthy controls. , 1992, The Journal of rheumatology.